83 related articles for article (PubMed ID: 26505354)
1. CCDC26 rs4295627 polymorphism (8q24.21) and glioma risk: a meta-analysis.
Lu HW; Huang M; Wang JH; Sun XL; Ke YQ
Genet Mol Res; 2015 Oct; 14(4):12074-84. PubMed ID: 26505354
[TBL] [Abstract][Full Text] [Related]
2. CCDC26 rs4295627 polymorphisms associated with an increased risk of glioma: A meta-analysis.
Zeng J; Luo Y; Yu M; Li J; Liu Z
Adv Clin Exp Med; 2017 Nov; 26(8):1275-1281. PubMed ID: 29264887
[TBL] [Abstract][Full Text] [Related]
3. CCDC26 rs4295627 polymorphism and glioma risk: a meta-analysis.
Cui T
Int J Clin Exp Med; 2015; 8(3):3862-8. PubMed ID: 26064285
[TBL] [Abstract][Full Text] [Related]
4. Association of the CCDC26 rs4295627 polymorphism with the risk of glioma: Evidence from 7,290 cases and 11,630 controls.
Wang X; Luo T; Ruan M; Liu P; Wang S; Zhu W
Mol Clin Oncol; 2016 May; 4(5):878-882. PubMed ID: 27123300
[TBL] [Abstract][Full Text] [Related]
5. The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: A meta-analysis.
Gao X; Mi Y; Yan A; Sha B; Guo N; Hu Z; Zhang N; Jiang F; Gou X
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e13-21. PubMed ID: 24935770
[TBL] [Abstract][Full Text] [Related]
6. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.
Wu Q; Peng Y; Zhao X
Mol Neurobiol; 2016 Sep; 53(7):4397-405. PubMed ID: 26243184
[TBL] [Abstract][Full Text] [Related]
7. Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis.
Wu Y; Zhou J; Zhang J; Tang Z; Chen X; Huang L; Liu S; Chen H; Wang Y
Front Oncol; 2023; 13():1180099. PubMed ID: 37746290
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma.
Tao Y; Liang G
Tumour Biol; 2014 Jan; 35(1):369-77. PubMed ID: 23963773
[TBL] [Abstract][Full Text] [Related]
9. The CDKN2A-CDKN2B rs4977756 polymorphism and glioma risk: a meta-analysis.
Lu H; Yang Y; Wang J; Liu Y; Huang M; Sun X; Ke Y
Int J Clin Exp Med; 2015; 8(10):17480-8. PubMed ID: 26770338
[TBL] [Abstract][Full Text] [Related]
10. Genetic Polymorphisms of CCDC26 rs891835, rs6470745, and rs55705857 in Glioma Risk: A Systematic Review and Meta-analysis.
González-Castro TB; Juárez-Rojop IE; López-Narváez ML; Tovilla-Zárate CA; Genis-Mendoza AD; Pérez-Hernández N; Martínez-Magaña JJ; Rodríguez-Pérez JM
Biochem Genet; 2019 Aug; 57(4):583-605. PubMed ID: 30778791
[TBL] [Abstract][Full Text] [Related]
11. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.
Qi X; Wan Y; Zhan Q; Yang S; Wang Y; Cai X
Mamm Genome; 2016 Feb; 27(1-2):1-7. PubMed ID: 26577493
[TBL] [Abstract][Full Text] [Related]
12. Association between GSTP1 Ile105Val polymorphism and glioma risk: a systematic review and meta-analysis.
Xie P; Liang Y; Liang G; Liu B
Tumour Biol; 2014 Jan; 35(1):493-9. PubMed ID: 23975366
[TBL] [Abstract][Full Text] [Related]
13. The association of 6 variants of 8q24 and the risk of glioma: A meta-analysis.
Tong Y; Ye L; Li S; Zhao F; Ying J; Qu Y; Li J; Mu D
Medicine (Baltimore); 2019 Jul; 98(27):e16205. PubMed ID: 31277128
[TBL] [Abstract][Full Text] [Related]
14. Association between telomerase reverse transcriptase rs2736100 polymorphism and risk of glioma.
Zhou P; Wei L; Xia X; Shao N; Qian X; Yang Y
J Surg Res; 2014 Sep; 191(1):156-60. PubMed ID: 24888789
[TBL] [Abstract][Full Text] [Related]
15. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.
Alpen K; Vajdic CM; MacInnis RJ; Milne RL; Koh ES; Hovey E; Harrup R; Bruinsma F; Nguyen TL; Li S; Joseph D; Benke G; Dugué PA; Southey MC; Giles GG; Rosenthal M; Drummond KJ; Nowak AK; Hopper JL; Kapuscinski M; Makalic E
Neuro Oncol; 2023 Jul; 25(7):1355-1365. PubMed ID: 36541697
[TBL] [Abstract][Full Text] [Related]
16. Association of the interleukin-4Rα rs1801275 and rs1805015 polymorphisms with glioma risk.
Guo J; Shi L; Li M; Xu J; Yan S; Zhang C; Sun G
Tumour Biol; 2014 Jan; 35(1):573-9. PubMed ID: 23979976
[TBL] [Abstract][Full Text] [Related]
17. The RTEL1 rs6010620 polymorphism and glioma risk: a meta-analysis based on 12 case-control studies.
Du SL; Geng TT; Feng T; Chen CP; Jin TB; Chen C
Asian Pac J Cancer Prev; 2014; 15(23):10175-9. PubMed ID: 25556444
[TBL] [Abstract][Full Text] [Related]
18. Association between the ERCC2 rs13181 polymorphism and the risk of glioma: a meta-analysis.
Jia TL; Wu HJ; Wang HB; Ma WB; Xing B
Genet Mol Res; 2015 Oct; 14(4):12577-84. PubMed ID: 26505408
[TBL] [Abstract][Full Text] [Related]
19. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
Jenkins RB; Wrensch MR; Johnson D; Fridley BL; Decker PA; Xiao Y; Kollmeyer TM; Rynearson AL; Fink S; Rice T; McCoy LS; Halder C; Kosel ML; Giannini C; Tihan T; O'Neill BP; Lachance DH; Yang P; Wiemels J; Wiencke JK
Cancer Genet; 2011 Jan; 204(1):13-8. PubMed ID: 21356187
[TBL] [Abstract][Full Text] [Related]
20. Interaction between 5 genetic variants and allergy in glioma risk.
Schoemaker MJ; Robertson L; Wigertz A; Jones ME; Hosking FJ; Feychting M; Lönn S; McKinney PA; Hepworth SJ; Muir KR; Auvinen A; Salminen T; Kiuru A; Johansen C; Houlston RS; Swerdlow AJ
Am J Epidemiol; 2010 Jun; 171(11):1165-73. PubMed ID: 20462933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
